Mark Jacobson - May 29, 2024 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Chief Operating Officer
Signature
/s/ Mark Jacobson
Stock symbol
AXSM
Transactions as of
May 29, 2024
Transactions value $
-$570,013
Form type
4
Date filed
5/29/2024, 08:12 PM
Previous filing
Apr 1, 2024
Next filing
Aug 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXSM Common Stock Options Exercise $17.8K +13.7K $1.30* 13.7K May 29, 2024 Direct F1
transaction AXSM Common Stock Sale -$588K -7.91K -57.77% $74.31 5.78K May 29, 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Options Exercise $0 -13.7K -100% $0.00* 0 May 29, 2024 Common Stock 13.7K $1.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an exercise of stock options prior to the 10-year expiration date of such options.
F2 Represents the subsequent sale of a portion of the underlying shares of the aforementioned exercise of stock options by the reporting person through a "sell to cover" transaction to satisfy tax withholding obligations and costs in connection with the aforementioned exercise of stock options.
F3 Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $73.99 and $74.52.